Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved ...
Hoth Therapeutics has filed two U.S. provisional patent applications that significantly expand its intellectual property ...
Hoth Therapeutics filed two provisional patent applications with the U.S. Patent and Trademark Office, expanding the ...
Greysun is the lead guides editor at Game Rant, covering all the biggest AAA titles to the smaller indie gems. He's been a big Nintendo fan since the SNES days and patiently awaits a Super Mario ...
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a ...
Hoth Therapeutics (HOTH) has delivered a -53.7300% change over the past year, with a 52-week range between 0.6554 and 3.8000. What Is the Average Daily Trading Volume of Hoth Therapeutics (HOTH)? The ...
NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Hoth Therapeutics (HOTH) (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback